Xenon Pharmaceuticals (XENE) Tops Q4 EPS by 1c

Xenon Pharmaceuticals (NASDAQ: XENE) reported Q4 EPS of ($0.84), $0.01 better than the analyst estimate of ($0.85).

For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Truist Securities Starts Matthews International (MATW) at Hold, 'We see risk/reward as more balanced'
• ZKH Group Limited (ZKH) Reports Q2 EPS of $0.04